Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiales Group Regulatory News (DIAL)

Share Price Information for Diales Group (DIAL)

Share Price is delayed by 15 minutes
Get Live Data
28.00    0.00 (0.00%)
Bid:
26.00
Ask:
30.00
Spread: 4.00 (15.385%)
Market Cap: £14.78m
DIAL Live PriceLast checked at - London Stock Exchange

Intraday Diales Group Share Chart

H1 FY25 trading update

24 Apr 2025 07:00

RNS Number : 9434F
Diales Group PLC
24 April 2025
 

Diales Group Plc

("Diales" or the "Company" or the "Group")

H1 FY25 trading update

Diales Group Plc (AIM: DIAL), the global specialist dispute avoidance and dispute resolution consultancy, today announces the following trading update for the six-month period ended 31 March 2025 (the "Period"). The Company expects to report its interim results for the Period on 10 June 2025.

The Board expects to report revenue and *underlying Group profit before tax for the Period similar to H1 FY24 and, on the basis of current trading, expects to deliver FY25 results in-line with current market expectations.

Trading performance

After returning to profitability in the financial year to 30 September 2023, the Group has continued to trade profitably since then and is performing well across its key markets in the UK, Europe and the Middle East. The Group's Canadian operations returned to profitability during the Period. As announced on 29 October 2024, the Group's USA operations are in the process of being closed down and, as such, treated as discontinued operations.

The implementation of the Company's four-year transformation strategy, launched in December 2023, continues to deliver efficiency gains and enhanced competitiveness and remains a key area of focus. The Company's key priorities include the acquisition of new talent to strengthen the services Diales offer, to deliver growth and expand in the markets served.

Financial position

The Group had a net cash balance of £2.3 million as at 31 March 2025 (FY24: £4.3 million, H1 FY24: £3.6 million). The movement is due mainly to £400,000 of dividends paid in the Period, £165,000 under the Company's ongoing share buyback programme, tax payments and a net increase in trade receivables which we expect to receive in Q3. The current net cash balance is c. £3.0 million post a further £400,000 of dividends paid on 10 April 2025.

The Group has recently put in place with Barclays Bank an overdraft facility of £1 million which is unutilised.

Mark Wheeler, Chief Executive Officer of Diales Group, commented:

"Q2 FY25 delivered increased momentum with the Group now busy across all areas, sectors and regions. With so much current turmoil in global markets, the Group is uniquely placed to assist with the impacts of tariffs, providing strategic guidance on supply chain challenges and cost escalation claims in the built environment. In this way, we can help our clients to navigate these issues and deliver growth to our business. I believe the Group is therefore well positioned to continue this momentum into H2 and deliver full year results in line with market expectations."

 *Underlying Group profit before tax is stated before share-based payment cost, discontinued operations and non-recurring costs

 

 Enquiries:

Diales Group Plc

Mark Wheeler, Chief Executive Officer

Charlotte Parsons, Chief Financial Officer

 

 

+44 (0)207 377 0005

+44 (0)207 496 3000

Shore Capital (Nominated Adviser and Broker)

Mark Percy

George Payne

 

+44 (0)207 408 4050

Acuitas Communications

 

Simon Nayyar

Jake Davis

+44 (0)203 745 0293 / +44 (0)779 976 7676 / 07848 157447

simon.nayyar@acuitascomms.com

jake.davis@acuitascomms.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUMUCUPAGBW
12
Date   Source Headline
27th May 20267:00 amRNSInvestor Presentation
21st May 20267:00 amRNSEBT Share Purchase
18th May 20264:37 pmRNSEBT Share Purchase
11th May 20269:56 amRNSEBT Share Purchase
8th May 20267:00 amRNSDirectorate change
5th May 202611:26 amRNSEBT Share Purchase
30th Apr 20267:00 amRNSTotal Voting Rights
27th Apr 202612:38 pmRNSEBT Share Purchase
23rd Apr 20267:00 amRNSTrading Update and Notice of Half-Year Results
20th Apr 20267:01 amRNSEBT Share Purchase
20th Apr 20267:00 amRNSGrant of Share Options under LTIP
16th Apr 20267:00 amRNSExercise of Share Options & TVR
31st Mar 20267:00 amRNSTotal Voting Rights
4th Mar 20267:00 amRNSExercise of Share Options and TVR
19th Feb 20265:14 pmRNSResult of AGM
30th Jan 20267:00 amRNSTotal Voting Rights
26th Jan 20261:27 pmRNSPosting of Annual Report & Notice of AGM
7th Jan 20267:00 amRNSExercise of Share Options and Total Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
12th Dec 20257:00 amRNSDirector/PDMR shareholding - acquisition of shares
9th Dec 20257:05 amRNSPDMR Dealing and Total Voting Rights
9th Dec 20257:00 amRNSPreliminary Results
25th Nov 20257:00 amRNSNotice of Results and Investor Presentation
24th Nov 20257:00 amRNSAppointment of Non-Executive Director
28th Oct 20257:00 amRNSYear End Trading Update
23rd Oct 202512:06 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSDirectorate Change
26th Aug 20257:00 amRNSAppointment of Non-Executive Chair
30th Jul 20257:00 amRNSDirector/PDMR Shareholding
26th Jun 20255:03 pmRNSHolding(s) in Company
24th Jun 20251:32 pmRNSShare buyback programme
13th Jun 20257:00 amRNSDirectorate Change
12th Jun 20257:00 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSInterim Report
30th May 20255:00 pmRNSTotal Voting Rights
27th May 20257:00 amRNSNotice of Results and Investor Presentation
30th Apr 20257:00 amRNSExercise of Share Options and Total Voting Rights
24th Apr 20257:00 amRNSH1 FY25 trading update
14th Apr 20257:02 amRNSAppointment of Nominated Adviser and Broker
14th Apr 20257:00 amRNSPurchase of Own Shares
8th Apr 20257:00 amRNSPurchase of Own Shares
1st Apr 20257:00 amRNSPurchase of Own Shares
28th Mar 20257:00 amRNSPurchase of Own Shares
20th Mar 20257:00 amRNSPurchase of Own Shares
18th Mar 20252:00 pmRNSFurther Share Buyback Programme
3rd Mar 20257:00 amRNSTotal Voting Rights
28th Feb 20253:30 pmRNSChange of Name
27th Feb 20253:27 pmRNSHolding(s) in Company
27th Feb 20258:45 amRNSResult of AGM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.